Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Sedentary time in adults and the association with diabetes, cardiovascular disease and death: systematic review and meta-analysis.

Wilmot EG, Edwardson CL, Achana FA, Davies MJ, Gorely T, Gray LJ, Khunti K, Yates T, Biddle SJ.

Diabetologia. 2012 Nov;55(11):2895-905. doi: 10.1007/s00125-012-2677-z. Epub 2012 Aug 14. Review. Erratum in: Diabetologia. 2013 Apr;56(4):942-3.

PMID:
22890825
2.

Sedentary time and its association with risk for disease incidence, mortality, and hospitalization in adults: a systematic review and meta-analysis.

Biswas A, Oh PI, Faulkner GE, Bajaj RR, Silver MA, Mitchell MS, Alter DA.

Ann Intern Med. 2015 Jan 20;162(2):123-32. doi: 10.7326/M14-1651. Review. Erratum in: Ann Intern Med. 2015 Sep 1;163(5):400.

PMID:
25599350
3.

Mortality in diabetes compared with previous cardiovascular disease: a gender-specific meta-analysis.

Lee C, Joseph L, Colosimo A, Dasgupta K.

Diabetes Metab. 2012 Nov;38(5):420-7. doi: 10.1016/j.diabet.2012.04.002. Epub 2012 Jun 7. Review.

PMID:
22682738
4.

Hormone therapy for preventing cardiovascular disease in post-menopausal women.

Boardman HM, Hartley L, Eisinga A, Main C, Roqué i Figuls M, Bonfill Cosp X, Gabriel Sanchez R, Knight B.

Cochrane Database Syst Rev. 2015 Mar 10;(3):CD002229. doi: 10.1002/14651858.CD002229.pub4. Review.

PMID:
25754617
5.

Television viewing and risk of type 2 diabetes, cardiovascular disease, and all-cause mortality: a meta-analysis.

Grøntved A, Hu FB.

JAMA. 2011 Jun 15;305(23):2448-55. doi: 10.1001/jama.2011.812.

6.

Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.

Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal TP, Hemmingsen C, Wetterslev J.

Cochrane Database Syst Rev. 2013 Nov 11;(11):CD008143. doi: 10.1002/14651858.CD008143.pub3. Review. Update in: Cochrane Database Syst Rev. 2015;(7):CD008143.

PMID:
24214280
7.

Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.

Sutcliffe P, Connock M, Gurung T, Freeman K, Johnson S, Kandala NB, Grove A, Gurung B, Morrow S, Clarke A.

Health Technol Assess. 2013 Sep;17(43):1-253. doi: 10.3310/hta17430. Review.

8.

Statins for the primary prevention of cardiovascular disease.

Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, Ward K, Ebrahim S.

Cochrane Database Syst Rev. 2013 Jan 31;(1):CD004816. doi: 10.1002/14651858.CD004816.pub5. Review.

PMID:
23440795
9.

Dipeptidyl peptidase-4 inhibitors and cardiovascular outcomes: meta-analysis of randomized clinical trials with 55,141 participants.

Wu S, Hopper I, Skiba M, Krum H.

Cardiovasc Ther. 2014 Aug;32(4):147-58. doi: 10.1111/1755-5922.12075. Review.

PMID:
24750644
10.

Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.

Hemmingsen B, Schroll JB, Lund SS, Wetterslev J, Gluud C, Vaag A, Sonne DP, Lundstrøm LH, Almdal T.

Cochrane Database Syst Rev. 2013 Apr 30;(4):CD009008. doi: 10.1002/14651858.CD009008.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;(7):CD009008.

PMID:
23633364
11.

Tea consumption and risk of cardiovascular outcomes and total mortality: a systematic review and meta-analysis of prospective observational studies.

Zhang C, Qin YY, Wei X, Yu FF, Zhou YH, He J.

Eur J Epidemiol. 2015 Feb;30(2):103-13. doi: 10.1007/s10654-014-9960-x. Epub 2014 Oct 30. Review.

PMID:
25354990
12.

[Sitting and cardiovascular morbidity and mortality].

Shiyovich A, Shlyakhover V, Katz A.

Harefuah. 2013 Jan;152(1):43-8, 58, 57. Review. Hebrew.

PMID:
23461028
13.

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.

Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Hegbrant J, Strippoli GF.

Cochrane Database Syst Rev. 2014 May 31;(5):CD007784. doi: 10.1002/14651858.CD007784.pub2. Review.

PMID:
24880031
14.
15.

Systematic versus opportunistic risk assessment for the primary prevention of cardiovascular disease.

Dyakova M, Shantikumar S, Colquitt JL, Drew CM, Sime M, MacIver J, Wright N, Clarke A, Rees K.

Cochrane Database Syst Rev. 2016 Jan 29;(1):CD010411. doi: 10.1002/14651858.CD010411.pub2. Review.

PMID:
26824223
16.

Fibrates for secondary prevention of cardiovascular disease and stroke.

Wang D, Liu B, Tao W, Hao Z, Liu M.

Cochrane Database Syst Rev. 2015 Oct 25;(10):CD009580. doi: 10.1002/14651858.CD009580.pub2. Review.

PMID:
26497361
17.

Relation of Smoking With Total Mortality and Cardiovascular Events Among Patients With Diabetes Mellitus: A Meta-Analysis and Systematic Review.

Pan A, Wang Y, Talaei M, Hu FB.

Circulation. 2015 Nov 10;132(19):1795-804. doi: 10.1161/CIRCULATIONAHA.115.017926. Epub 2015 Aug 26. Review.

18.

Association between various sedentary behaviours and all-cause, cardiovascular disease and cancer mortality: the Multiethnic Cohort Study.

Kim Y, Wilkens LR, Park SY, Goodman MT, Monroe KR, Kolonel LN.

Int J Epidemiol. 2013 Aug;42(4):1040-56. doi: 10.1093/ije/dyt108.

19.

Perioperative beta-blockers for preventing surgery-related mortality and morbidity.

Blessberger H, Kammler J, Domanovits H, Schlager O, Wildner B, Azar D, Schillinger M, Wiesbauer F, Steinwender C.

Cochrane Database Syst Rev. 2014 Sep 18;(9):CD004476. doi: 10.1002/14651858.CD004476.pub2. Review.

PMID:
25233038
20.

Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis.

Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ, Strippoli GF.

JAMA. 2011 Mar 16;305(11):1119-27. doi: 10.1001/jama.2011.308. Review.

PMID:
21406649

Supplemental Content

Support Center